Markets

Why You Shouldn't Bet Against Abeona Therapeutics (ABEO) Stock

A pen next to a calculator.
Credit: Shutterstock photo

One stock that might be an intriguing choice for investors right now is Abeona Therapeutics Inc.ABEO .This is because this security in the Medical Biomedical/Genetics space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.

This is important because, often times, a rising tide will lift all boats in an industry, as there can be broad trends taking place in a segment that are boosting securities across the board. This is arguably taking place in the Medical Biomedical/Genetics space as it currently has a Zacks Industry Rank of 74 out of more than 250 industries, suggesting it is well-positioned from this perspective, especially when compared to other segments out there.

Meanwhile, Abeona Therapeutics is actually looking pretty good on its own too. The firm has seen solid earnings estimate revision activity over the past month, suggesting analysts are becoming a bit more bullish on the firm's prospects in both the short and long term.

In fact, over the past month, current quarter estimates have narrowed from a loss of 11 cents per share to a loss of 9 cents per share, while current year estimates have narrowed from a loss of 45 cents per share to a loss of 39 cents per share. The company currently carries a Zacks Rank #3 (Hold), which is also a favorable signal

So, if you are looking for a decent pick in a strong industry, consider Abeona Therapeutics. Not only is its industry currently in the top third, but it is seeing solid estimate revisions as of late, suggesting it could be a very interesting choice for investors seeking a name in this great industry segment.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

ABEONA THERAPTC (ABEO): Free Stock Analysis Report

To read this article on Zacks.com click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ABEO

Other Topics

Investing Stocks

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More